BMS-929075
CAS No. 1217338-97-0
BMS-929075( —— )
Catalog No. M34188 CAS No. 1217338-97-0
BMS-929075 is an orally active HCV NS5B replicase (HCV NS5B replicase) palm site variant inhibitor with potency, high oral bioavailability and pharmacokinetic parameters.BMS-929075 shows cytotoxicity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 289 | Get Quote |
|
| 5MG | 456 | Get Quote |
|
| 10MG | 653 | Get Quote |
|
| 25MG | 994 | Get Quote |
|
| 50MG | 1362 | Get Quote |
|
| 100MG | 1791 | Get Quote |
|
| 500MG | 3528 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBMS-929075
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-929075 is an orally active HCV NS5B replicase (HCV NS5B replicase) palm site variant inhibitor with potency, high oral bioavailability and pharmacokinetic parameters.BMS-929075 shows cytotoxicity.
-
DescriptionBMS-929075 is a potent and orally active HCV NS5B replicase palm site allosteric inhibitor. BMS-929075 shows high oral bioavailability. BMS-929075 shows cytotoxicity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHCV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1217338-97-0
-
Formula Weight538.54
-
Molecular FormulaC31H24F2N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(=O)C1=CC(=C(C)C=C1)C=2C(F)=C3C(C(NC)=O)=C(OC3=CC2)C4=CC=C(F)C=C4)C5(CC5)C=6N=CC=CN6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Proadrenomedullin (1...
Endogenous peptide agonist of Mas related GPR X2 (MRGPRX2, EC50 = 251 nM). Also a noncompetitive nicotinic cholinergic antagonist. Inhibits nicotine-stimulated catecholamine secretion from PC12 cells in vitro, and from sympathetic nerve endings and adrenal chromaffin cells in vivo. Corresponds to amino acids 1 - 20 of proadrenomedullin. Antihypertensive.
-
IMS2186
IMS2186 is a reagent with activity of antichoroidal neovascularization (CNV). IMS2186 could arrest cancer cell cycle in G2/M phase, result in exerting anti-proliferation and anti-angiogenesis effects.
-
3-O-methylellagic ac...
3-O-methylellagic acid 4'-O-alpha-L-rhamnopyranoside is a natural product for research related to life sciences.
Cart
sales@molnova.com